CliffBio
small molecule

THYROSAFE

POTASSIUM IODIDE

Loss of exclusivity—loss of exclusivity
CompanyBTG INTERNATIONAL INC

Drug detail

Brand nameTHYROSAFE
Active ingredientPOTASSIUM IODIDE
Strength130MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 2025
Marketing statusOTC

More from BTG INTERNATIONAL INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.